Nūhou

Pono ʻoe e heluhelu i kēia kūkākūkā a me ka nānā ʻana o kā mākou kūlana kālā a me nā hopena hana, a me nā ʻōlelo kālā a me nā memo i hoʻopaʻa ʻole ʻia i loko o ka hōʻike hapaha makahiki ma ka Form 10-Q, a me kā mākou mau hōʻike kālā a me nā moʻolelo no ka makahiki i pau Kekemapa 31, 2020 a me ke kūkākūkā a me ka nānā ʻana o ka hoʻokele pili i nā kūlana kālā a me nā hopena hana, aia ia mau mea ʻelua i kā mākou hōʻike makahiki ma ka Pepa 10-K no ka makahiki i pau i ka lā 31 Kekemapa 2020 (“2020 Form 10-K ”).
Loaʻa i kēia hōʻike hapaha makahiki ma ka Form 10-Q nā ʻōlelo e nānā i mua i hana ʻia e like me nā ʻōlelo palekana o ke awa palekana o ka Private Securities Litigation Reform Act o 1995 ma lalo o ka Pauku 27A o ka Securities Act o 1933 (ka "Securities Act"), a me ka hoʻoponopono hou ʻia ʻo 1934 Securities Exchange Article 21E o ke kānāwai. ʻO nā ʻōlelo e nānā i mua ma mua o nā ʻōlelo o nā ʻike mōʻaukala i loko o kēia hōʻike hapaha, me nā ʻōlelo e pili ana i kā mākou hana hana e hiki mai ana a me ke kūlana kālā, nā hoʻolālā pāʻoihana, nā hoʻolālā R&D a me nā kumukūʻai, ka hopena o COVID-19, ka manawa a me nā hiki, ka waiho ʻana a me ka ʻae. , Nā hoʻolālā pāʻoihana, ke kumu kūʻai a me ka uku hou ʻana, ka hiki ke hoʻomohala i nā moho huahana e hiki mai ana, ka manawa a me ka hiki ke kūleʻa i nā hoʻolālā hoʻokele hana e hiki mai ana a me nā pahuhopu, a me nā hopena i manaʻo ʻia e hiki mai ana o ka hana hoʻomohala huahana nā ʻōlelo i mua. Hana ʻia kēia mau ʻōlelo ma ka hoʻohana ʻana i nā huaʻōlelo e like me "hiki", "will", "manaʻo", "manaʻo", "manaʻo", "manaʻo", "hiki", "pono", "manaʻo" a "hoʻomau" a nā ʻōlelo like a i ʻole nā ​​ʻano like ʻole. ʻO nā ʻōlelo i mua o kēia hōʻike hapahā he mau wānana wale nō. Hoʻokumu ʻia kā mākou mau ʻōlelo i mua i kā mākou mau manaʻo a me nā wānana o nā hanana e hiki mai ana a me nā ʻano kālā. Ke manaʻoʻiʻo nei mākou e pili ana kēia mau hanana a me nā ʻano kālā i kā mākou kūlana kālā, ka hana hana, ka hoʻolālā ʻoihana, nā hana ʻoihana pōkole a lōʻihi a me nā pahuhopu. Ua hoʻopuka ʻia kēia mau ʻōlelo i mua i ka lā o kēia hōʻike hapaha makahiki a ua kau ʻia i nā pilikia he nui, nā kānalua a me nā manaʻo, me nā mea i wehewehe ʻia ma ka helu 1A ma lalo o ke poʻomanaʻo "Risk Factors" ma ka Māhele II. ʻAʻole ʻike ʻia a ʻike ʻia paha nā hanana a me nā kūlana i ʻike ʻia i kā mākou mau ʻōlelo i mua, a ʻokoʻa paha nā hopena maoli mai nā wānana i nā ʻōlelo i mua. Inā ʻaʻole i koi ʻia e ke kānāwai pili, ʻaʻole mākou i manaʻo e hoʻonui a hoʻoponopono hou i nā ʻōlelo e nānā ana i mua i loko o kēia, inā paha ma muli o kekahi ʻike hou, nā hanana e hiki mai ana, nā loli i nā kūlana a i ʻole nā ​​kumu ʻē aʻe.
ʻO Marizyme kahi hui ʻepekema ola multi-technology platform me kahi kahua huahana i hoʻāʻo ʻia a patented no ka mālama ʻana i ka myocardial a me ka vein graft, protease therapy no ka hōʻeha ʻeha, thrombosis a me ke olakino holoholona. Ua kūpaʻa ʻo Marizyme i ka loaʻa ʻana, hoʻomohala a kūʻai aku i nā lāʻau lapaʻau, nā lako a me nā huahana pili e mālama ai i ka ola cell a kākoʻo i ka metabolism, a laila hoʻolaha i ke olakino cell a me ka hana maʻamau. ʻO kā mākou waiwai maʻamau i kēia manawa i ka pae QB o OTC Markets ma lalo o ke code "MRZM". Ke hana ikaika nei ka ʻoihana i ka hoʻopaʻa inoa ʻana i kāna kumukūʻai maʻamau ma ka mākeke kūʻai Nasdaq i loko o nā mahina he ʻumikumamālua e hiki mai ana ma hope o ka lā o kēia hōʻike. Hiki iā mākou ke nānā i nā koho no ka papa inoa ʻana o kā mākou waiwai maʻamau ma New York Stock Exchange ("New York Stock Exchange").
Krillase-Ma o kā mākou loaʻa ʻana o ka ʻenehana Krillase mai ACB Holding AB i ka makahiki 2018, ua kūʻai mākou i kahi EU noiʻi a me ka loiloi protease kahua lapaʻau i hiki ke mālama i nā ʻeha mau a me nā kuni a me nā noi lapaʻau ʻē aʻe. ʻO Krillase kahi lāʻau lapaʻau i helu ʻia ma ke ʻano he lāʻau lapaʻau Class III ma ʻEulopa no ka mālama ʻana i nā ʻeha mau. Loaʻa ʻia ka enzyme Krill mai Antarctic krill a me nā crustacean ʻoʻo. He hui ia o ka endopeptidase a me ka exopeptidase, hiki ke hoʻoheheʻe me ka palekana i nā mea organik. ʻO ka hui ʻana o ka protease a me ka peptidase ma Krillase e kōkua i ka krill Antarctic e ʻeli a wāwahi i ka meaʻai i loko o ke anuanu ʻo Antarctica. No laila, hāʻawi kēia hōʻiliʻili enzyme kūikawā i nā mana "ʻoki" kūʻokoʻa. Ma ke ʻano he "pahi biochemical", hiki i ka Krillase ke hoʻoheheʻe i nā mea olaola, e like me ka necrotic tissue, thrombotic substances, a me nā biofilms i hana ʻia e nā microorganism. No laila, hiki ke hoʻohana ʻia e hōʻoluʻolu a mālama i nā ʻano maʻi like ʻole o ke kanaka. No ka laʻana, hiki iā Krillase ke hoʻopau palekana a hoʻopau pono i nā plaques thrombosis arterial, hoʻoikaika i ka ho'ōla wikiwiki a kākoʻo i nā grafts ʻili e mālama i nā ʻeha mau a me nā kuni, a e hōʻemi i nā biofilm bacteria e pili ana i ke olakino waha maikaʻi ʻole i nā kānaka a me nā holoholona.
Ua loaʻa iā mākou kahi laina huahana e pili ana iā Krillase, e kālele ana i ka hoʻomohala ʻana i nā huahana no ka mālama ʻana i nā maʻi he nui i ka mākeke mālama koʻikoʻi. ʻO kēia ka mea i hōʻike ʻia i ka haki ʻana o kā mākou Killase hoʻomohala pipeline i manaʻo ʻia:
Ua kūpono ʻo Krillase ma ke ʻano he lāʻau lapaʻau ma ka European Union ma Iulai 19, 2005, no ka debridement o nā ʻeha hohonu a me ka mānoanoa o nā maʻi maʻi.
E like me ka lā i hoʻouna ʻia ai kēia palapala, e hoʻomau ka ʻoihana i ka loiloi ʻana i ka ʻoihana, ke kauka, ka noiʻi, a me nā manaʻo hoʻoponopono e pili ana i ke kūʻai ʻana i kā mākou laina huahana e pili ana iā Krillase. ʻO kā mākou hoʻolālā pāʻoihana no ka hoʻomohala ʻana i kēia laina huahana ʻelua mau ʻano:
Manaʻo mākou e hoʻopau i ka hoʻomohala ʻana, ka hana a me ka hoʻolālā ʻoihana o ka platform Krillase e 2022, a manaʻo mākou e hoʻohua i ka pūʻulu mua o nā loaʻa kūʻai huahana ma 2023.
DuraGraft-Ma o kā mākou loaʻa ʻana iā Somah i Iulai 2020, ua loaʻa iā mākou kāna huahana ʻike koʻikoʻi e pili ana i ka ʻenehana pale pale cell e pale ai i ka pōʻino ischemic i nā kino a me nā ʻiʻo i ka wā o ka hoʻololi ʻana a me nā hana hoʻololi. ʻO kāna mau huahana a me nā huahana moho, i kapa ʻia ʻo nā huahana Somah, e komo pū me DuraGraft, kahi hoʻomaʻamaʻa intraoperative vascular graft hoʻokahi manawa no ka vascular and bypass surgery, hiki ke mālama i ka hana endothelial a me ke ʻano, a laila e hōʻemi i ka hopena a me nā hoʻopiʻi o ka hana ʻole ʻana. A e hoʻomaikaʻi i ka hopena lapaʻau ma hope o ke kaʻina bypass.
ʻO DuraGraft kahi "hoʻopiʻi hōʻeha endothelial" kūpono no ka bypass cardiac, peripheral bypass a me nā ʻoki vascular ʻē aʻe. Lawe ʻo ia i ka hōʻailona CE a ʻae ʻia no ke kūʻai aku ma 33 mau ʻāina/wīwī ma 4 mau ʻāina, me ka ʻaʻole i kaupalena ʻia i ka European Union, Turkey, Singapore, Hong Kong, India, Philippines, a me Malaysia. Hoʻopili pū ʻo Somahlution i ka hoʻomohala ʻana i nā huahana e hōʻemi i ka hopena o ka ʻeha ischemia-reperfusion i nā hana transplant ʻē aʻe a me nā hōʻailona ʻē aʻe kahi e hōʻeha ai ka ischemic i ka maʻi. ʻO nā huahana like ʻole i loaʻa mai ka ʻenehana pale pale cell no nā hōʻailona he nui i nā pae like ʻole o ka hoʻomohala ʻana.
Wahi a ka hōʻike loiloi mākeke, ʻo ka honua coronary artery bypass graft market ka waiwai ma kahi o US $ 16 biliona. Mai 2017 a 2025, manaʻo ʻia e ulu ka mākeke ma kahi helu ulu makahiki o 5.8% (Grand View Research, Malaki 2017). Ma ke ao holoʻokoʻa, ua manaʻo ʻia aia ma kahi o 800,000 CABG ʻokiʻoki e hana ʻia i kēlā me kēia makahiki (Grand View Research, Malaki 2017), ʻo ia mau hana i hana ʻia ma ʻAmelika Hui Pū ʻIa no ka hapa nui o ka nui o nā ʻokiʻoki honua. Ma ʻAmelika Hui Pū ʻIa, ua manaʻo ʻia aia ma kahi o 340,000 mau hana CABG e hana ʻia i kēlā me kēia makahiki. Ua manaʻo ʻia ma ka makahiki 2026, e hāʻule ka nui o nā hana CABG ma kahi o 0.8% i kēlā me kēia makahiki a i lalo o 330,000 i kēlā me kēia makahiki, ma muli o ka hoʻohana ʻana i ka percutaneous coronary intervention (ʻike ʻia ʻo "angioplasty") lāʻau lapaʻau a me ka ʻenehana. Holomua (idata noiʻi, Kepakemapa 2018).
I ka makahiki 2017, ʻo ka nui o nā hana vascular peripheral e like me ka angioplasty a me ka peripheral arterial bypass, phlebectomy, thrombectomy, a me endarterectomy ma kahi o 3.7 miliona. Manaʻo ʻia ka nui o nā ʻokiʻoki vascular peripheral e ulu ma kahi helu ulu makahiki o 3.9% ma waena o 2017 a me 2022, a ua manaʻo ʻia e ʻoi aku ma mua o 4.5 miliona e 2022 (Research and Markets, ʻOkakopa 2018).
Ke hana nei ka hui me nā mea hoʻolaha kūloko o nā huahana pili i ka maʻi cardiovascular e kūʻai aku a hoʻonui i ka māhele mākeke o DuraGraft ma ʻEulopa, ʻAmelika Hema, Australia, ʻApelika, ka Middle East a me ka Far East e like me nā koi hoʻoponopono kūloko. E like me ka lā i hoʻouna ʻia ai kēia palapala, manaʻo ka ʻoihana e hoʻouna i kahi noi de novo 510k i ʻAmelika Hui Pū ʻIa i ka lua o ka hapaha o 2022 a ke manaʻo nei e ʻae ʻia ia ma ka hopena o 2022.
Manaʻo ʻia ʻo DuraGraft e hoʻouna i kahi noi de novo 510k, a ke manaʻo nei ka hui e hoʻouna i kahi palapala hoʻouna mua i ka FDA, e wehewehe ana i ka hoʻolālā e hōʻoia i ka palekana a me ka pono o ka huahana. ʻO ka noi a ka FDA no ka hoʻohana ʻana iā DuraGraft i ke kaʻina CABG e manaʻo ʻia e hana ʻia ma 2022.
E hoʻomaka ana ka hoʻolālā kalepa ʻo DuraGraft i hōʻailona ʻia e CE a me nā hoa hoʻolaha i koho ʻia i nā ʻāina ʻEulopa a me ʻAsia i ka hapaha lua o 2022, e hoʻohana ana i nā ala i manaʻo ʻia e pili ana i ka loaʻa ʻana o ka mākeke, nā KOL i loaʻa, ka ʻikepili lapaʻau, a me ka loaʻa kālā. E hoʻomaka ana ka hui e hoʻomohala i ka mākeke US CABG no DuraGraft ma o ka hoʻomohala ʻana i nā KOL, nā paʻi i loaʻa, nā noiʻi lapaʻau i koho ʻia, ke kūʻai aku ʻana a me nā ala kūʻai he nui.
Ua loaʻa iā mākou nā poho i kēlā me kēia manawa mai ko mākou hoʻokumu ʻana. No nā mahina ʻeiwa i pau i Sepatemaba 30, 2021 a me 2020, ʻo kā mākou poho ʻupena ma kahi o US $ 5.5 miliona a me US $ 3 miliona. Manaʻo mākou e loaʻa nā lilo a me nā poho hana i nā makahiki e hiki mai ana. No laila, pono mākou i nā kālā hou e kākoʻo i kā mākou mau hana hoʻomau. E ʻimi mākou e hāʻawi kālā i kā mākou mau hana ma o ka hoʻopuka ʻana i ke kaulike o ka lehulehu a pilikino paha, ke kālā hōʻaiʻē, ke aupuni a i ʻole ke kālā ʻaoʻao ʻē aʻe, ka hui pū ʻana a me nā hoʻonohonoho laikini. ʻAʻole hiki iā mākou ke loaʻa i nā kālā hou aʻe ma nā ʻōlelo kūpono a i ʻole. ʻO kā mākou hiki ʻole ke hōʻiliʻili kālā i ka wā e pono ai e hoʻopilikia i kā mākou mau hana hoʻomau a loaʻa ka hopena maikaʻi ʻole i ko mākou kūlana kālā a me ko mākou hiki ke hoʻokō i nā hoʻolālā ʻoihana a hoʻomau i nā hana. Pono mākou e hoʻonui i ka loaʻa kālā e loaʻa ai ka waiwai, a ʻaʻole hiki iā mākou ke hana.
Ma Nowemapa 1, 2021, ua hoʻopaʻa inoa ʻo Marizyme a me Health Logic Interactive Inc. (“HLII”) i kahi ʻaelike hoʻonohonoho hope loa ma lalo o ka loaʻa ʻana o ka hui ʻo My Health Logic Inc., kahi ʻoihana nona piha o HLII (“HLII”). "MHL"). "kālepa").
E hoʻokō ʻia ke kālepa ma o kahi hoʻolālā o ka hoʻonohonoho ʻana ma lalo o ke Kānāwai ʻoihana ʻoihana (British Columbia). E like me ka hoʻolālā o ka hoʻonohonoho ʻana, e hoʻopuka ʻo Marizyme i ka huina o 4,600,000 mau ʻāpana maʻamau i HLII, e kau ʻia i kekahi mau ʻōlelo a me nā palena. I ka pau ʻana o ke kālepa, e lilo ʻo My Health Logic Inc. Manaʻo ʻia e hoʻopau ʻia ka hana ma mua a ma mua paha o Dekemaba 31, 2021.
Hāʻawi ka loaʻa iā Marizyme i ke komo ʻana i nā mea hoʻohana diagnostic point-of-care e pili ana i ka poʻe maʻi e pili ana i nā smartphones a me kahi kahua mālama mālama hoʻomau i hoʻomohala ʻia e MHL. Hoʻolālā ʻo My Health Logic Inc. e hoʻohana i kāna ʻenehana lab-on-a-chip patent-pending no ka hāʻawi ʻana i nā hopena wikiwiki a hoʻomaʻamaʻa i ka hoʻoili ʻana o ka ʻikepili mai nā mea hana diagnostic i nā smartphones o nā maʻi. Manaʻo ʻo MHL e hiki i kēia hōʻiliʻili ʻikepili ke loiloi maikaʻi i ka ʻike pilikia o nā maʻi a hāʻawi i nā hopena maʻi maikaʻi aʻe. ʻO ka mikiona o My Health Logic Inc. ʻo ia ka mea e hiki ai i nā kānaka ke hana i ka ʻike mua ʻana i ka maʻi maʻi maʻi maʻi ma o ka hoʻokele digital operable i kēlā me kēia manawa, ma nā wahi āpau.
Ma hope o ka pau ʻana o ke kaʻina hana, e loaʻa i ka hui nā lako diagnostic digital MHL MATLOC1. ʻO MATLOC 1 kahi ʻenehana ʻenehana diagnostic platform e hoʻomohala ʻia e hoʻāʻo i nā biomarkers like ʻole. I kēia manawa, ua kālele ʻo ia i nā biomarkers biomarkers mimi albumin a me ka creatinine no ka nānā ʻana a me ka hōʻoia hope o ka maʻi maʻi maʻi maʻi. Manaʻo ka hui e hāʻawi ʻia ka polokalamu MATLOC 1 i ka FDA no ka ʻae ʻia ma ka hopena o 2022, a manaʻo ka hoʻokele e ʻae ʻia ia ma waena o 2023.
Ma Mei 2021, ua hoʻomaka ka hui i kahi hoʻonohonoho pilikino e like me ke Kumukānāwai 506 o ka Securities Act, me ka nui o 4,000,000 mau ʻāpana ("hoʻopuka"), me nā memo hoʻololi a me nā palapala kauoha, i manaʻo ʻia e hoʻonui i 10,000,000 US kālā ma ke ʻano holo. . Ua hoʻoponopono hou ʻia kekahi mau ʻōlelo a me nā kūlana o ke kūʻai aku ma Kepakemapa 2021. I loko o ka manawa ʻeiwa mau mahina e pau ana i ka lā 30 Kepakemapa 2021, kūʻai aku ka hui a hoʻopuka i ka huina o 522,198 mau ʻāpana me ka huina kālā he US $1,060,949. E hoʻohana ʻia nā mea i loaʻa mai ka hoʻopuka ʻana e mālama i ka ulu ʻana o ka ʻoihana a hoʻokō i kāna mau kuleana kapikala.
I loko o ka manawa ʻeiwa mau mahina e pau ana i ka mahina ʻo Kepakemapa 30, 2021, ke hana nei ʻo Marizyme i ka hoʻoponopono hou ʻana i ka hui, kahi i hoʻololi ai nā luna koʻikoʻi, nā alakaʻi, a me nā hui hoʻokele e hoʻolalelale i ke kaʻina hana o ka ʻoihana e hoʻokō i kāna mau pahuhopu nui a hoʻokō i nā hoʻolālā. Ma hope o ka pau ʻana a me ka hoʻopau ʻana o ke kālepa MHL, manaʻo ka hui i nā hoʻololi hou aʻe i kāna hui hoʻokele nui e hoʻoponopono hou a hoʻomaikaʻi i ka hana holoʻokoʻa o ka hui.
Hōʻike ka loaʻa i ka huina o nā kūʻai huahana me nā uku lawelawe a me nā hoʻihoʻi huahana. No kā mākou hoahele hoʻolaha, ʻike mākou i ka loaʻa kālā kūʻai huahana ke hāʻawi ʻia ka huahana i kā mākou hoa hāʻawi. Ma muli o ka lā pau o kā mākou huahana, inā pau ka huahana, e hoʻololi mākou i ka huahana me ka uku ʻole. I kēia manawa, loaʻa mai kā mākou loaʻa kālā a pau mai ke kūʻai aku ʻana iā DuraGraft ma nā mākeke ʻEulopa a me ʻAsia, a ua hoʻokō nā huahana i kēia mau mākeke i nā ʻae kānāwai e koi ʻia.
ʻO nā kumukūʻai loaʻa pololei ka nui o nā kumukūʻai huahana, ʻo ia hoʻi nā koina āpau e pili pono ana i ke kūʻai ʻana i nā lako maka, nā lilo o kā mākou hui hana ʻaelike, nā kumukūʻai hana ʻole, a me nā lilo o ka lawe ʻana a me ka hāʻawi ʻana. Hoʻokomo pū ʻia nā kumukūʻai loaʻa pololei i nā poho ma muli o ka nui, ka neʻe lohi a i ʻole ka wā kahiko a me nā hoʻopaʻa kūʻai kūʻai waihona (inā loaʻa).
ʻO nā uku ʻoihana e pili ana i nā uku kānāwai e pili ana i ka hoʻomohala ʻana i ka waiwai noʻonoʻo a me nā ʻoihana hui, a me nā uku kūkākūkā no nā lawelawe ʻike kālā, kālā a me ka loiloi. Manaʻo mākou i ka piʻi ʻana o ke kumukūʻai o ka loiloi, kānāwai, hoʻoponopono, a me nā lawelawe pili i ka ʻauhau e pili ana i ka mālama ʻana i ka hoʻokō ʻana i ka papa inoa hoʻololi a me nā koi o Securities and Exchange Commission.
Loaʻa i ka uku ka uku a me nā lilo o nā limahana pili. ʻO ka uku i hoʻopaʻa ʻia i ka waiwai e hōʻike ana i ka waiwai kūpono o nā makana i hoʻoholo ʻia e ka hui i kāna mau limahana, nā mana, nā alakaʻi, a me nā mea kūkākūkā. Ua helu ʻia ka waiwai kūpono o ka makana me ka hoʻohana ʻana i ke kumu kumu kumu kūʻai koho Black-Scholes, e noʻonoʻo ana i kēia mau kumu: ke kumu kūʻai hoʻoikaika kino, ke kumu kūʻai o ka mākeke o kēia manawa o ke kumu waiwai, ka manaʻolana o ke ola, ka uku pānaʻi pilikia ʻole, ka volatility i manaʻo ʻia, ka loaʻa kālā, a holo wikiwiki.
ʻO nā lilo ʻē aʻe a me ka hoʻokele nui e pili ana i nā lilo kūʻai aku a me ke kūʻai aku, nā kumukūʻai hale, nā hoʻokele a me nā keʻena, nā uku ʻinikua no nā alakaʻi a me nā limahana kiʻekiʻe, a me nā kumukūʻai pili kālā e pili ana i ka hana ʻana i kahi hui i helu ʻia.
ʻO nā loaʻa a me nā lilo ʻē aʻe e pili ana i ka hoʻololi ʻana i ke kumukūʻai makeke o nā aie koʻikoʻi i manaʻo ʻia no ka loaʻa ʻana o Somah, a me ka uku ukupanee a me ka mahalo e pili ana i nā palapala hoʻololi i hāʻawi ʻia e mākou ma lalo o ka ʻaelike kūʻai.
Hōʻuluʻulu ka papa aʻe i kā mākou hopena hana no nā mahina ʻeiwa i pau i ka lā 30 Kepakemapa 2021 a me 2020:
Ua hōʻoia mākou ʻo ka loaʻa kālā no nā mahina ʻeiwa i pau i ka lā 30 Kepakemapa 2021 he US$270,000, a ʻo ka loaʻa kālā no nā mahina ʻeiwa i pau i Kepakemapa 30, 2020 he US$120,000. ʻO ka piʻi ʻana o ka loaʻa kālā i ka wā hoʻohālikelike e pili ana i ka piʻi ʻana o ke kūʻai aku o DuraGraft, i loaʻa ma ke ʻano he ʻāpana o ke kālepa Somah.
I loko o nā mahina ʻeiwa i pau i ka lā 30 o Kepakemapa, 2021, ua loaʻa iā mākou ke kumu kūʻai pololei o ka loaʻa kālā o $170,000, ʻo ia ka piʻi ʻana a hiki i 150,000 US kālā. Ke hoʻohālikelikeʻia me ka uluʻana o ka loaʻa kālā, ua hoʻonuiʻia ke kumukūʻai o ke kūʻaiʻana i ka wikiwiki wikiwiki. ʻO kēia ma muli o ka nele o nā mea waiwai i hoʻokumu ʻia e ka maʻi maʻi COVID-19, e pili pono ana i ke kumukūʻai o ka loaʻa ʻana, pale a me ka loaʻa ʻana o nā mea kiʻekiʻe kiʻekiʻe.
No ka manawa e pau ana i ka la 30 o Kepakemapa, 2021, ua hoʻonui ʻia nā uku ʻoihana e US$1.3 miliona, a i ʻole 266%, i US$1.81 miliona, i hoʻohālikelike ʻia me US $490,000 a hiki i Kepakemapa 30, 2020. Ua hana ka hui i kekahi mau hana ʻoihana, me ka loaʻa ʻana. ʻO ka hui Somah a me ka hoʻoponopono hou ʻana o ka hui, i hopena i ka piʻi nui ʻana o nā uku loio i kekahi manawa. ʻO ka hoʻonui ʻana i nā uku ʻoihana ʻo ia hoʻi ka hopena o ka hoʻomākaukau ʻana o ka hui no ka ʻae ʻana o FDA a me ka holomua a me ka hoʻomohala ʻana i nā pono waiwai naʻauao. Eia kekahi, hilinaʻi ʻo Marizyme i kekahi mau hui kūkākūkā o waho e kiaʻi i nā ʻano he nui o ka ʻoihana, me ka ʻoihana kālā a me nā hana moʻohelu kālā. I nā mahina ʻeiwa i pau i ka lā 30 Kepakemapa, 2021, ua hoʻomaka pū ʻo Marizyme i kahi kālepa kūʻai kūʻai lehulehu, e hoʻolaha hou ana i ka piʻi ʻana o nā uku ʻoihana i ka wā.
ʻO nā uku uku no ka manawa e pau ana iā Kepakemapa 30, 2021 he USD 2.48 miliona, he piʻi o USD 2.05 miliona a i ʻole 472% ma luna o ka manawa hoʻohālikelike. ʻO ka hoʻonui ʻana i nā kumukūʻai uku e pili ana i ka hoʻonohonoho hou ʻana a me ka ulu ʻana o ka hui ʻoiai e hoʻomau ka ʻoihana i ka hoʻonui ʻana i nā mākeke hou a ua kūpaʻa ʻo ia i ke kālepa ʻana o DuraGraft ma United States.
No nā mahina ʻeiwa i pau i ka lā 30 o Kepakemapa, 2021, ua hoʻonui ʻia nā koina maʻamau a me nā hoʻokele e US $600,000 a i ʻole 128% a i ka US$1.07 miliona. ʻO ka piʻi ʻana ma muli o ka hoʻoponopono hou ʻana o ka ʻoihana, ka ulu ʻana, a me ka hoʻonui ʻana i nā kumukūʻai kūʻai aku a me nā pilina lehulehu e pili ana i ka hoʻolaha ʻana i ka hōʻailona huahana a me nā kumukūʻai, i hopena mai ka hana ʻana i kahi ʻoihana i helu ʻia. Ke hoʻolālā nei mākou e hoʻomau i ka hoʻonui ʻana i nā hana hoʻokele a me nā ʻoihana, manaʻo mākou e piʻi aʻe nā lilo maʻamau a me ka hoʻokele i ka wā e hiki mai ana.
I loko o ka manawa ʻeiwa mau mahina e pau ana i ka lā 30 Kepakemapa 2021, ua hoʻomaka ka hui i ke kūʻai aku, kahi i hoʻokomo ʻia ai nā hoʻopau ʻana he nui i nā pūʻulu. ʻO nā uku ukupanee a me nā kumukūʻai i hoʻohui ʻia me nā memo hoʻololi i hoʻopuka ʻia ma ke ʻano he ʻāpana o ka ʻaelike hāʻawi.
Eia hou, ua hōʻoia ka hui i ka loaʻa kālā kūpono o $ 470,000, me ka hoʻololi ʻana i ke kumukūʻai mākeke o nā kuleana koʻikoʻi i manaʻo ʻia e ka loaʻa ʻana o Somah.
Hōʻuluʻulu ka papa ʻaina i kā mākou hopena hana no nā mahina ʻekolu i pau i ka lā 30 Kepakemapa 2021 a me 2020:
Ua hōʻoia mākou ʻo ka loaʻa kālā no nā mahina ʻekolu i pau i Kepakemapa 30, 2021 he US $040,000, a ʻo ka loaʻa kālā no nā mahina ʻekolu i pau i Kepakemapa 30, 2020 he US$120,000, he emi o ka makahiki ma ka makahiki he 70%. I loko o nā mahina ʻekolu i pau i ka lā 30 Kepakemapa, 2021, ua loaʻa iā mākou ke kumu kūʻai pololei o ka loaʻa kālā o US $ 0.22 miliona, ʻo ia ka emi ʻana i hoʻohālikelike ʻia i ke kumukūʻai pololei o ka loaʻa kālā o US $ 0.3 miliona i nā mahina ʻekolu i pau i ka lā 30 Kepakemapa 2020. 29 %.
ʻO ka maʻi maʻi COVID-19 ka mea i hoʻopau i nā lako maka a me ka hoʻopau ʻana i ke kaulahao lako honua. Eia kekahi, ma 2021, e kālele ana nā hoa ʻoihana o Marizyme i ka hoʻoponopono ʻana i nā pono hana kūikawā o ke aupuni US i ka hakakā ʻana i ka maʻi maʻi COVID-19. Eia kekahi, i ka makahiki 2021, ma muli o ka nui o ka ʻōnaehana olakino a me nā pilikia e pili ana i ka hoʻihoʻi ʻana o ka maʻi i ka wā o ka maʻi maʻi, ua hōʻole ke koi no ka ʻoki koho. He hopena maikaʻi ʻole kēia mau mea āpau i ka loaʻa kālā o ka ʻoihana a me ke kumukūʻai kūʻai kūʻai no nā mahina ʻekolu i pau i ka lā 30 Kepakemapa 2021.
Ua hoʻonui ʻia nā uku ʻoihana no nā mahina ʻekolu i pau i Kepakemapa 30, 2021 e USD 390,000 i ka USD 560,000, i hoʻohālikelike ʻia me USD 170,000 no nā mahina ʻekolu i pau i ka lā 30 Kepakemapa 2020. loaʻa nā waiwai a me nā aie i manaʻo ʻia.
ʻO nā uku uku no nā mahina ʻekolu i pau i ka lā 30 Kepakemapa 2021 he $620,000, he piʻi o $180,000 a i ʻole 43% ma luna o ka manawa hoʻohālikelike. ʻO ka piʻi ʻana o nā kumukūʻai uku e pili ana i ka ulu ʻana o ka hui i ka hoʻomau ʻana o ka ʻoihana i nā mākeke hou a ua kūpaʻa ʻo ia i ka hoʻolaha ʻana o DuraGraft ma United States.
I loko o nā mahina ʻekolu e pau ana i ka lā 30 o Kepakemapa, 2021, ua hoʻonui ʻia nā lilo maʻamau a me ka hoʻokele ʻana e US $0.8 miliona a i ʻole 18% i US $500,000. ʻO ke kumu nui o ka hoʻonui ʻana ʻo ia ke kānāwai, hoʻoponopono a me ka hana pono e pili ana i ka loaʻa ʻana o My Health Logic Inc.
I loko o nā mahina ʻekolu e pau ana i ka lā 30 Kepakemapa 2021, ua hoʻopau ka hui i ka lua a me ke kūʻai nui loa a hoʻopuka i ka helu kiʻekiʻe o nā memo hoʻololi a hiki i kēia lā. ʻO nā uku ukupanee a me nā kumukūʻai i hoʻohui ʻia me nā memo hoʻololi i hoʻopuka ʻia ma ke ʻano he ʻāpana o ka ʻaelike hāʻawi.
I loko o nā mahina ʻekolu i pau i ka lā 30 o Kepakemapa, 2021, ua ʻike ka ʻoihana i ka loaʻa kālā kūpono o US $190,000, i hoʻoponopono ʻia i ke kumukūʻai mākeke e pili ana i nā kuleana koʻikoʻi i manaʻo ʻia i ka wā i loaʻa ai ʻo Somah.
Mai ko mākou hoʻokumu ʻana, ua hoʻopuka kā mākou ʻoihana hana i nā poho ʻupena a me ke kahe kālā maikaʻi ʻole, a ke manaʻo ʻia nei e hoʻomau mākou i nā poho ʻupena i ka wā e hiki mai ana. Ma ka lā 30 o Kepakemapa, 2021, loaʻa iā mākou he $16,673 i ke kālā a me nā mea like.
I Mei 2021, ua ʻae ka papa o Marizyme i ka hui e hoʻomaka i ke kūʻai aku a kūʻai aku i 4,000,000 mau ʻāpana ("ʻāpana") ma ke kumukūʻai o US $2.50 no kēlā me kēia. Loaʻa i kēlā me kēia ʻāpana (i) kahi palapala hoʻohiki hiki ke hoʻololi ʻia i ke kumu kūʻai maʻamau o ka hui, me ke kumu kūʻai mua o US$2.50 no kēlā me kēia mahele, a (ii) kahi palapala hoʻopaʻa no ke kūʻai ʻana i hoʻokahi mahele o ka waiwai maʻamau o ka hui ("Class. He Palapala Kauoha”)); (iii) ʻO ka palapala kauoha ʻelua no ke kūʻai ʻana i ke kumukūʻai maʻamau o ka hui ("Class B Warrant").
I nā mahina ʻeiwa i pau i ka mahina ʻo Kepakemapa 2021, ua hoʻopuka ka hui i ka huina o 469,978 mau ʻāpana e pili ana i ke kūʻai aku, me ka huina kālā he $1,060,949.
Ma Sepatemaba 29, 2021, ua hoʻoponopono ka hui i ka ʻaelike hui ʻo Mei 2021 me ka ʻae o nā mea paʻa a pau. Ma ka hoʻihoʻi ʻana i ka hoʻopukapuka, ua ʻae ka mea paʻa i ka ʻāpana e hoʻololi i ka ʻaelike kūʻai ʻāpana, e hopena i kēia mau hoʻololi i ka hoʻopuka:
Ua hoʻoholo ka hui ʻaʻole lawa ka hoʻololi ʻana i ka ʻaelike kūʻai ʻāpana e manaʻo ʻia he mea koʻikoʻi, a no laila ʻaʻole i hoʻololi i ka waiwai o nā mea kani kumu i hoʻopuka ʻia. Ma muli o kēia hoʻololi ʻana, ua hoʻololi ʻia ka huina o 469,978 mau ʻāpana i hoʻopuka mua ʻia me ka huina o 522,198 mau ʻāpana prorated.
Manaʻo ka hui e hoʻonui i ka US $ 10,000,000 ma ke ʻano holo. E hoʻohana ʻia nā mea i loaʻa mai ka hoʻopuka ʻana e mālama i ka ulu ʻana o ka ʻoihana a hoʻokō i kāna mau kuleana kapikala.